Are 3-repeat (3R) and 4-repeat (4R) tau protein isoforms considered biomarkers for the unmet clinical needs in the diagnosis and management of tauopathies?
The 3R and 4R tau isoforms have potential as biomarkers in tauopathies, particularly for conditions characterized by predominant 4R pathology such as PSP and CBD. Continued research and validation are needed to utilize their full diagnostic and therapeutic potential effectively.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-10-29
- DOI
- https://doi.org/10.5281/zenodo.23767500
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00